AzTrials
AzTrials

Autism Spectrum DisorderASDANCT06375226

Autism and Attachment. An Explorative Study of Attachment Styles in Autistic Adults.

An observational study of Autism Spectrum Disorder, run by Parnassia Groep at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study examines the relationship between attachment and autism spectrum disorder (ASD) in adults. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Autism Spectrum Disorder
How many people
32 participants
Where
1 siteNetherlands
Study dates
1 Mar 2024to 1 May 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Adults (>18 years) with ASD, and without intellectual disability. Participants will be recruited from SARR Autism Rotterdam and Antes, both part of Parnassia Group in the Netherlands. SARR Autism Rotterdam is specialized in psychodiagnostic assessments and interventions for children, adolescents, and adults with ASD. Antes and Parnassia Group are multisite mental health institutes specialized in psychodiagnostic assessments and interventions for adults with a broad range of psychiatric disorders, including ASD.

Who may be able to join

  • a primary clinical diagnosis of DSM-5 ASD (APA, 2013)
  • age 18 - 65 years
  • no intellectual disability (IQ > 80)

Who cannot join

  • acute psychosis
  • acute suicidality
  • psychotic disorder
  • intellectual disability (IQ < 80)

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • ParnassiaGroep Antes

    Rotterdam, South Holland, 3083 AK

Other trials in Netherlands

About this study

Official title: Autism Spectrum Disorder and Attachment. An Explorative Study of Attachment Styles in Adults With Autism Spectrum Disorder

The present study examines the relationship between attachment and autism spectrum disorder (ASD) in adults.

Read the detailed description

Rationale: Previous research on autism spectrum disorder (ASD) and attachment has improved understanding of the aetiology and development of the disorder. Research on adults with ASD, however is scarce. The study is focussed on attachment in adults with ASD. Objective: The aim of the current study is to explore attachment styles of adults with ASD and examining the relationship between attachment and ASD.

The study requires 60 participants.

Keywords
Autism Spectrum Disorder, Attachtment, Adults
Medical subject headings
Autism Spectrum Disorder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Social Responsiveness Scale - Adult version (SRS-A)

    The SRS-A is a screening tool for identifying possible ASD characteristics in adults suspicious for ASD, is 64-item self-report questionnaire measuring various dimensions of interpersonal behavior, communication, and rigid, repetitive behaviour and interests, characteristic for adults with ASD. Each item is rated on a 1-4 point scale.

    Measured: 15 minutes

  2. The Attachment Styles Questionnaire (ASQ)

    The ASQ is a questionnaire consisting of 24 items and assesses four attachment styles (secure, preoccupied, fearful, and dismissing). The 5-point rating scale ranges from 1 (strongly disagree) to 5 (strongly agree).

    Measured: 15 minutes

  3. Experiences in Close Relationships - Revised questionnaire (ECR-r)

    The ECR-r measures adult attachment within romantic relationships in past and present in 36 items, consisting of two subscales of 18 items each (attachment anxiety and attachment avoidance). Each item is rated from 'strongly disagree' (1) to 'strongly agree' (7).

    Measured: 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2024
  2. Study start1 Mar 2024
  3. Primary completion1 May 2025
  4. Study completion1 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06375226
Sponsor's protocol ID
2023.17
Other IDs
2023.0871
Acronym
ASDA
Status last verified
Jun 2026
First submitted
16 Apr 2024
Last updated
26 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder, run by Parnassia Groep at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Social Responsiveness Scale - Adult version (SRS-A) (time frame: 15 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in